Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-08-07
DOI
10.1111/imr.13252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chimeric Antigen Receptor T-Cell Therapy
- (2023) Shawna K. Brookens et al. CANCER JOURNAL
- γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
- (2023) Natasja L. de Vries et al. NATURE
- Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
- (2023) David S. Hong et al. NATURE MEDICINE
- Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
- (2023) Marcel P. Trefny et al. Nature Communications
- Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects
- (2023) Xiao Wang et al. Cancers
- Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity
- (2023) Chengsong Yan et al. CANCER CELL
- T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
- (2023) Daniel Hirschhorn et al. CELL
- A neutrophil response linked to tumor control in immunotherapy
- (2023) Jeremy Gungabeesoon et al. CELL
- Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy
- (2023) Shizhen Geng et al. JOURNAL OF CONTROLLED RELEASE
- FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
- (2023) Yifan Liu et al. Journal of Translational Medicine
- Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation
- (2023) Brandon Cieniewicz et al. MOLECULAR THERAPY
- TET2 guards against unchecked BATF3-induced CAR T cell expansion
- (2023) Nayan Jain et al. NATURE
- Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy
- (2023) Cristina Puig-Saus et al. NATURE
- Co-opting signalling molecules enables logic-gated control of CAR T cells
- (2023) Aidan M. Tousley et al. NATURE
- CAR immune cells: design principles, resistance and the next generation
- (2023) Louai Labanieh et al. NATURE
- Author Correction: T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
- (2023) Maria M. Steele et al. NATURE IMMUNOLOGY
- Orthogonal engineering of synthetic T cell states to enhance cancer immunotherapy
- (2023) Alberto G. Conti et al. NATURE IMMUNOLOGY
- Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells
- (2023) Jesus Corria-Osorio et al. NATURE IMMUNOLOGY
- ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors
- (2023) Yeonsun Hong et al. NATURE IMMUNOLOGY
- Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
- (2023) Andras Heczey et al. NATURE MEDICINE
- Long-term outcomes following CAR T cell therapy: what we know so far
- (2023) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
- (2023) Francesca Del Bufalo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
- (2023) Jiaqi Fan et al. RADIOTHERAPY AND ONCOLOGY
- T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
- (2023) Deborah Meyran et al. Science Translational Medicine
- Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells
- (2023) Alexandra L. Pourzia et al. Cell Death & Disease
- Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating
- (2023) Mohamad Hamieh et al. Cancer Discovery
- Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer
- (2023) Apostolia M. Tsimberidou et al. Cancer Immunology Research
- Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade
- (2023) Luke Frankiw et al. Journal for ImmunoTherapy of Cancer
- Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors
- (2023) Konstantinos Lontos et al. Journal for ImmunoTherapy of Cancer
- Barriers to immune cell infiltration in tumors
- (2023) Marit M Melssen et al. Journal for ImmunoTherapy of Cancer
- Targeting Cbl-b in cancer immunotherapy
- (2023) Ryan C. Augustin et al. Journal for ImmunoTherapy of Cancer
- Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
- (2023) Jianghui Tang et al. Journal for ImmunoTherapy of Cancer
- Metabolic challenges and interventions in CAR T cell therapy
- (2023) Jhan-Jie Peng et al. Science Immunology
- Anti-TIGIT therapies for solid tumors: a systematic review
- (2023) A. Rousseau et al. ESMO Open
- mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
- (2023) Irene Olivera et al. Cell Reports Medicine
- Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors
- (2022) Parvin Akbari et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A roadmap for driving CAR T cells toward the oncogenic immunopeptidome
- (2022) Melita Irving et al. CANCER CELL
- Magnesium sensing via LFA-1 regulates CD8+ T cell effector function
- (2022) Jonas Lötscher et al. CELL
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- CRISPR activation and interference screens decode stimulation responses in primary human T cells
- (2022) Ralf Schmidt et al. SCIENCE
- CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience
- (2022) M Lia Palomba et al. Journal for ImmunoTherapy of Cancer
- Rapid manufacturing of non-activated potent CAR T cells
- (2022) Saba Ghassemi et al. Nature Biomedical Engineering
- High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
- (2022) Soyoung A. Oh et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
- (2022) Changsong Qi et al. NATURE MEDICINE
- PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
- (2022) Vivek Narayan et al. NATURE MEDICINE
- Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
- (2022) Smita S. Chandran et al. NATURE MEDICINE
- Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders
- (2022) Nicholas A. Maskalenko et al. NATURE REVIEWS DRUG DISCOVERY
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Costimulatory CAR Improves TCR-based Cancer Immunotherapy
- (2022) Bilal Omer et al. Cancer Immunology Research
- Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy
- (2022) Kristin G Anderson et al. Journal for ImmunoTherapy of Cancer
- Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
- (2022) Julia A. Belk et al. CANCER CELL
- cBAF complex components and MYC cooperate early in CD8+ T cell fate
- (2022) Ao Guo et al. NATURE
- Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
- (2022) Filippo Birocchi et al. Science Translational Medicine
- Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells
- (2022) Li Li et al. Scientific Reports
- NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
- (2022) Mikiya Ishihara et al. Journal for ImmunoTherapy of Cancer
- High-performance multiplex drug-gated CAR circuits
- (2022) Hui-Shan Li et al. CANCER CELL
- High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity
- (2022) Rodrigo Vazquez-Lombardi et al. IMMUNITY
- Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
- (2022) Jiqin Zhang et al. NATURE
- Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma
- (2022) Alexandra Gyurdieva et al. Nature Communications
- Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety
- (2022) Nicholas A. Vitanza et al. Cancer Discovery
- Enforcing GLUT3 expression in CD8+ T cells improves fitness and tumor control by promoting glucose uptake and energy storage
- (2022) Elisabetta Cribioli et al. Frontiers in Immunology
- CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
- (2022) Elisabetta Cribioli et al. Frontiers in Immunology
- The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better
- (2022) Rui Mao et al. Frontiers in Immunology
- Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
- (2022) Anže Smole et al. CANCER CELL
- Engineered T cell therapy for viral and non-viral epithelial cancers
- (2022) Scott M. Norberg et al. CANCER CELL
- Non-viral precision T cell receptor replacement for personalized cell therapy
- (2022) Susan P. Foy et al. NATURE
- IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer
- (2022) Joonbeom Bae et al. NATURE CELL BIOLOGY
- IL-2 engineered MSCs rescue T cells in tumours
- (2022) Melita Irving et al. NATURE CELL BIOLOGY
- Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning
- (2022) Kyle G. Daniels et al. SCIENCE
- Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
- (2021) Max Jan et al. Science Translational Medicine
- Utility of Safety Switch to Abrogate CD19.CAR T Cell-Associated Neurotoxicity
- (2021) Matthew C Foster et al. BLOOD
- In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer
- (2021) Zeyu Chen et al. CELL
- TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
- (2021) Nisha B. Nagarsheth et al. NATURE MEDICINE
- Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
- (2021) Max Jan et al. Nature Reviews Clinical Oncology
- Direct control of CAR T cells through small molecule-regulated antibodies
- (2021) Spencer Park et al. Nature Communications
- A chimeric GM-CSF/IL18 receptor to sustain CAR T-cell function
- (2021) Shannon Lange et al. Cancer Discovery
- Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
- (2021) Darel Martínez Bedoya et al. Frontiers in Immunology
- A transgene-encoded truncated human epidermal growth factor receptor for depletion of anti- B-cell maturation antigen CAR-T cells
- (2021) Qingming Wang et al. CELLULAR IMMUNOLOGY
- Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
- (2021) Evan W. Weber et al. SCIENCE
- SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
- (2021) Joseph H. Choe et al. Science Translational Medicine
- A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy
- (2021) Eric J. Hsu et al. Nature Communications
- The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
- (2021) Yannick D. Muller et al. Frontiers in Immunology
- TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma
- (2021) Kyung-Eun Noh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs
- (2021) Nadia Anikeeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CAR T-cell therapy for solid tumours
- (2021) The Lancet Oncology LANCET ONCOLOGY
- BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
- (2021) Hyungseok Seo et al. NATURE IMMUNOLOGY
- Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
- (2021) Yugang Guo et al. NATURE IMMUNOLOGY
- CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
- (2021) Jay Y. Spiegel et al. NATURE MEDICINE
- Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
- (2021) Benjamin C. Creelan et al. NATURE MEDICINE
- Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
- (2021) Nicholas A. Vitanza et al. NATURE MEDICINE
- A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
- (2021) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- Clinical and therapeutic relevance of cancer-associated fibroblasts
- (2021) Yang Chen et al. Nature Reviews Clinical Oncology
- Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol
- (2021) Linfeng Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
- (2021) Alexander I. Salter et al. Science Signaling
- Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
- (2021) Fernanda G Herrera et al. Cancer Discovery
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
- (2021) Prasad S Adusumilli et al. Cancer Discovery
- CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function
- (2021) Ali Can Sahillioglu et al. Cancer Immunology Research
- Engineered Cytokine Signaling to Improve CAR T Cell Effector Function
- (2021) Matthew Bell et al. Frontiers in Immunology
- Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy
- (2021) Xianhui Chen et al. Molecular Therapy-Oncolytics
- Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors
- (2021) Bruno L. Cadilha et al. Science Advances
- VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding
- (2021) Evripidis Lanitis et al. Journal for ImmunoTherapy of Cancer
- Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors
- (2021) Bettina Kotter et al. Cancers
- T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
- (2021) Stefanie Lesch et al. Nature Biomedical Engineering
- Control of the activity of CAR-T cells within tumours via focused ultrasound
- (2021) Yiqian Wu et al. Nature Biomedical Engineering
- Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control
- (2021) Ian C. Miller et al. Nature Biomedical Engineering
- CD19 directed CAR T cell therapy for treatment of primary CNS lymphoma
- (2021) Tanya Siddiqi et al. Blood Advances
- Kynurenines as a Novel Target for the Treatment of Malignancies
- (2021) Adrian Mor et al. Pharmaceuticals
- Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy
- (2021) Nils Wellhausen et al. CURRENT OPINION IN IMMUNOLOGY
- Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells
- (2021) Melita Irving et al. HUMAN GENE THERAPY
- Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
- (2021) Mark Yarmarkovich et al. NATURE
- Sensitive identification of neoantigens and cognate TCRs in human solid tumors
- (2021) Marion Arnaud et al. NATURE BIOTECHNOLOGY
- Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy
- (2021) Oliver Van Oekelen et al. NATURE MEDICINE
- A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia
- (2021) Qian Zhang et al. Science Translational Medicine
- Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
- (2021) Brooke Prinzing et al. Science Translational Medicine
- Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
- (2021) Luis Felipe Olguín-Contreras et al. Frontiers in Immunology
- Improved lentiviral vector titers from a multi-gene knockout packaging line
- (2021) Jiaying Han et al. Molecular Therapy-Oncolytics
- Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity
- (2020) Nina Dumauthioz et al. Cellular & Molecular Immunology
- CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma
- (2020) Guangna Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
- (2020) Greta Giordano-Attianese et al. NATURE BIOTECHNOLOGY
- Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy
- (2020) Greta Giordano-Attianese et al. NATURE BIOTECHNOLOGY
- Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
- (2020) Michael D. Crowther et al. NATURE IMMUNOLOGY
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Engineering light-controllable CAR T cells for cancer immunotherapy
- (2020) Ziliang Huang et al. Science Advances
- Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
- (2020) Katharina Zimmermann et al. Cancers
- Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
- (2020) Theodore L. Roth et al. CELL
- The role of antigen-spreading in the efficacy of immunotherapies
- (2020) Peter Brossart CLINICAL CANCER RESEARCH
- Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor
- (2020) Nicholas G. Minutolo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response
- (2020) Xinghuo Li et al. LEUKEMIA
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
- (2020) Johanna Theruvath et al. NATURE MEDICINE
- The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
- (2020) Won Jin Ho et al. Nature Reviews Clinical Oncology
- Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties
- (2020) Kento Fujiwara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity
- (2020) Livingstone Fultang et al. BLOOD
- A functional screening strategy for engineering chimeric antigen receptors with reduced on-target, off-tumour activation
- (2020) Raphaël B. Di Roberto et al. MOLECULAR THERAPY
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4+ T cells
- (2020) Jan A. Rath et al. Science Advances
- MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
- (2020) Annelisa M. Cornel et al. Cancers
- Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
- (2020) Ulrich T. Hacker et al. Cancers
- convertibleCARs: A chimeric antigen receptor system for flexible control of activity and antigen targeting
- (2020) Kyle E. Landgraf et al. Communications Biology
- All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy
- (2020) Evripidis Lanitis et al. CURRENT OPINION IN BIOTECHNOLOGY
- The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
- (2020) Shogo Kumagai et al. NATURE IMMUNOLOGY
- Designed protein logic to target cells with precise combinations of surface antigens
- (2020) Marc J. Lajoie et al. SCIENCE
- Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
- (2020) Claire Gorby et al. Science Signaling
- Safety and Tolerability of Adoptive Cell Therapy in Cancer
- (2019) Benita Wolf et al. DRUG SAFETY
- NR4A transcription factors limit CAR T cell function in solid tumours
- (2019) Joyce Chen et al. NATURE
- CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
- (2019) Mohamad Hamieh et al. NATURE
- T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
- (2019) Tori N. Yamamoto et al. JOURNAL OF CLINICAL INVESTIGATION
- A cetuximab-mediated suicide system in CAR-modified hematopoietic stem cells for cancer therapy
- (2019) Roy L. Kao et al. HUMAN GENE THERAPY
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2019) Miguel F. Sanmamed et al. CELL
- CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
- (2019) Nicholas F. Kuhn et al. CANCER CELL
- CD19 CAR T cell product and disease attributes predict leukemia remission durability
- (2019) Olivia C. Finney et al. JOURNAL OF CLINICAL INVESTIGATION
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- Chimeric Antigen Receptor T-Cells: The Future is Now
- (2019) Wassim Mchayleh et al. Journal of Clinical Medicine
- Modulation of chimeric antigen receptor surface expression by a small molecule switch
- (2019) Alexandre Juillerat et al. BMC BIOTECHNOLOGY
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
- (2019) Smita S. Chandran et al. IMMUNOLOGICAL REVIEWS
- The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells
- (2019) Michael Bachmann IMMUNOLOGY LETTERS
- TOX is a critical regulator of tumour-specific T cell differentiation
- (2019) Andrew C. Scott et al. NATURE
- TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
- (2019) Omar Khan et al. NATURE
- Gene editing for immune cell therapies
- (2019) Stefanie R. Bailey et al. NATURE BIOTECHNOLOGY
- TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion
- (2019) Hyungseok Seo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
- (2019) Katrin Mestermann et al. Science Translational Medicine
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages
- (2019) Marco Orecchioni et al. Frontiers in Immunology
- Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
- (2019) Kilian Schober et al. Nature Biomedical Engineering
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression, Role, and Regulation of Neutrophil Fcγ Receptors
- (2019) Yu Wang et al. Frontiers in Immunology
- A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
- (2019) Shiran Hoogi et al. Journal for ImmunoTherapy of Cancer
- The tumor vasculature an attractive CAR T cell target in solid tumors
- (2019) Parvin Akbari et al. ANGIOGENESIS
- Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
- (2019) U Dafni et al. ANNALS OF ONCOLOGY
- The Acidic Tumor Microenvironment as a Driver of Cancer
- (2019) Ebbe Boedtkjer et al. Annual Review of Physiology
- Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
- (2019) Imran G. House et al. CLINICAL CANCER RESEARCH
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function
- (2019) Sharyn Thomas et al. Nature Communications
- CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
- (2019) Linchun Jin et al. Nature Communications
- Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
- (2019) Fan Zou et al. Nature Communications
- CD8 Binding of MHC-Peptide Complexes in cis or trans Regulates CD8+ T-cell Responses
- (2019) Yang Liu et al. JOURNAL OF MOLECULAR BIOLOGY
- c-Jun overexpression in CAR T cells induces exhaustion resistance
- (2019) Rachel C. Lynn et al. NATURE
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen
- (2019) Gwennaëlle C. Monnot et al. Molecular Therapy-Oncolytics
- Cell Biology of T Cell Receptor Expression and Regulation
- (2018) Andrés Alcover et al. Annual Review of Immunology
- CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
- (2018) Masao Hashimoto et al. Annual Review of Medicine
- CRISPR/Cas9-mediated knockout of DGK improves anti-tumor activities of human T cells
- (2018) In-Young Jung et al. CANCER RESEARCH
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
- (2018) Jang Hwan Cho et al. CELL
- T-cell responses toTP53"hotspot" mutations and unique neoantigens expressed by human ovarian cancers
- (2018) Drew C Deniger et al. CLINICAL CANCER RESEARCH
- Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
- (2018) Akiko Seki et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Rewiring T-cell responses to soluble factors with chimeric antigen receptors
- (2018) ZeNan L Chang et al. Nature Chemical Biology
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanogenetics for the remote and noninvasive control of cancer immunotherapy
- (2018) Yijia Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy
- (2018) Mayrel Labrada et al. SEMINARS IN ONCOLOGY
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Remote Control of Mammalian Cells with Heat-Triggered Gene Switches and Photothermal Pulse Trains
- (2018) Ian C. Miller et al. ACS Synthetic Biology
- Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
- (2018) Mauro P. Avanzi et al. Cell Reports
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation
- (2018) Pradip Bajgain et al. Journal for ImmunoTherapy of Cancer
- Programming CAR-T cells to kill cancer
- (2018) Louai Labanieh et al. Nature Biomedical Engineering
- Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape
- (2018) Carl DeSelm et al. MOLECULAR THERAPY
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
- (2018) Joseph A. Fraietta et al. NATURE
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
- (2018) Alexander I. Salter et al. Science Signaling
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- VISTA expressed in tumour cells regulates T cell function
- (2018) Kumuluzi Mulati et al. BRITISH JOURNAL OF CANCER
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
- (2018) Eric Shifrut et al. CELL
- Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease
- (2018) Roger Li et al. EUROPEAN UROLOGY
- Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
- (2018) Judith Feucht et al. NATURE MEDICINE
- Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory
- (2018) Sophie Viaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
- (2018) Quinlan L. Sievers et al. SCIENCE
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells
- (2017) Le Qin et al. Journal of Hematology & Oncology
- Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
- (2017) Daniel T. Harris et al. JOURNAL OF IMMUNOLOGY
- T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
- (2017) Robert Sackstein et al. LABORATORY INVESTIGATION
- CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
- (2017) Andras Heczey et al. MOLECULAR THERAPY
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
- (2017) Somala Mohammed et al. MOLECULAR THERAPY
- Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
- (2017) Thomas Shum et al. Cancer Discovery
- CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes
- (2017) Zhilong Zhao et al. Oncotarget
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- An oxygen sensitive self-decision making engineered CAR T-cell
- (2017) Alexandre Juillerat et al. Scientific Reports
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
- (2017) Melita Irving et al. Frontiers in Immunology
- HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer
- (2017) Kendra C. Foley et al. Molecular Therapy-Oncolytics
- Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy
- (2017) et al. Cancers
- Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity
- (2017) Spencer Park et al. Scientific Reports
- Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
- (2017) Weiqiang Zhou et al. CURRENT MEDICINAL CHEMISTRY
- Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer
- (2016) Yu Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
- (2016) Oladapo O. Yeku et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
- (2016) Xiaojun Liu et al. CANCER RESEARCH
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
- (2016) Nicole E. Scharping et al. IMMUNITY
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
- (2016) M Cartellieri et al. Blood Cancer Journal
- TGF 1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
- (2016) B. V. Park et al. Cancer Discovery
- Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
- (2016) Eloah Rabello Suarez et al. Oncotarget
- Domain-swapped T cell receptors improve the safety of TCR gene therapy
- (2016) Michael T Bethune et al. eLife
- Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization
- (2016) K. Newick et al. Cancer Immunology Research
- A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration
- (2016) R. Sakemura et al. Cancer Immunology Research
- CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
- (2016) Shu Su et al. Scientific Reports
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy
- (2015) K. Pilipow et al. CANCER RESEARCH
- Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
- (2015) Shari Pilon-Thomas et al. CANCER RESEARCH
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- Targeting cancer-specific mutations by T cell receptor gene therapy
- (2015) Thomas Blankenstein et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting the tumor vasculature to enhance T cell activity
- (2015) Evripidis Lanitis et al. CURRENT OPINION IN IMMUNOLOGY
- The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
- (2015) Gustavo J. Martinez et al. IMMUNITY
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy
- (2015) Sebastian Kobold et al. JNCI-Journal of the National Cancer Institute
- Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression
- (2015) Kevin J Curran et al. MOLECULAR THERAPY
- Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma
- (2015) Joal D Beane et al. MOLECULAR THERAPY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
- (2015) Roy L. Maute et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
- (2015) C.-Y. Wu et al. SCIENCE
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy
- (2015) Sebastian Kobold et al. JNCI-Journal of the National Cancer Institute
- ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
- (2014) S. Guedan et al. BLOOD
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor
- (2014) Ann M Leen et al. MOLECULAR THERAPY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
- (2014) Zhi-Fu Tao et al. ACS Medicinal Chemistry Letters
- T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression
- (2014) S. P. Santoro et al. Cancer Immunology Research
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
- (2013) M. J. Besser et al. CLINICAL CANCER RESEARCH
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
- (2013) Joel Crespo et al. CURRENT OPINION IN IMMUNOLOGY
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
- (2013) Jan C. Dudda et al. IMMUNITY
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
- (2013) Eric Tran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
- (2013) Sunitha Kakarla et al. MOLECULAR THERAPY
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
- (2013) V. D. Fedorov et al. Science Translational Medicine
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Structural and Biophysical Insights into the Role of CD4 and CD8 in T Cell Activation
- (2013) Yili Li et al. Frontiers in Immunology
- Structure-Based, Rational Design of T Cell Receptors
- (2013) V. Zoete et al. Frontiers in Immunology
- Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages
- (2012) Spencer Park et al. BIOMATERIALS
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- TGFβ signaling plays a critical role in promoting alternative macrophage activation
- (2012) Dapeng Gong et al. BMC IMMUNOLOGY
- CAR T cells transform to trucks: chimeric antigen receptor–redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer
- (2012) Markus Chmielewski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
- (2012) K. Tamada et al. CLINICAL CANCER RESEARCH
- Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy
- (2012) L Zhang et al. GENE THERAPY
- The molecular determinants of CD8 co-receptor function
- (2012) David K. Cole et al. IMMUNOLOGY
- Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+T Cell Responsiveness
- (2012) Melita Irving et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
- (2012) Jin-Ping Lai et al. MODERN PATHOLOGY
- Tumor PD-L1 co-stimulates primary human CD8+ cytotoxic T cells modified to express a PD1:CD28 chimeric receptor
- (2012) Megan E. Prosser et al. MOLECULAR IMMUNOLOGY
- Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
- (2012) Christopher C Kloss et al. NATURE BIOTECHNOLOGY
- TALENs: a widely applicable technology for targeted genome editing
- (2012) J. Keith Joung et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance
- (2012) B. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-targeted TNF stabilizes tumor vessels and enhances active immunotherapy
- (2012) A. Johansson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
- (2011) D.-G. Song et al. BLOOD
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
- (2011) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains
- (2011) D H Aggen et al. GENE THERAPY
- Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice
- (2011) Ana Caterina Parente-Pereira et al. JOURNAL OF CLINICAL IMMUNOLOGY
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
- (2010) J. C. Markley et al. BLOOD
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
- (2010) W. Peng et al. CLINICAL CANCER RESEARCH
- Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
- (2010) Scott Wilkie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
- (2010) Dhanalakshmi Chinnasamy et al. JOURNAL OF CLINICAL INVESTIGATION
- Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice
- (2010) Ingunn M. Stromnes et al. JOURNAL OF CLINICAL INVESTIGATION
- Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells
- (2010) D. Sommermeyer et al. JOURNAL OF IMMUNOLOGY
- Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
- (2010) D. A. Schmid et al. JOURNAL OF IMMUNOLOGY
- Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
- (2010) John A. Craddock et al. JOURNAL OF IMMUNOTHERAPY
- Tumor Secretion of VEGF Induces Endothelial Cells to Suppress T cell Functions Through the Production of PGE2
- (2010) Jennifer K. Mulligan et al. JOURNAL OF IMMUNOTHERAPY
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Synthetic biology: applications come of age
- (2010) Ahmad S. Khalil et al. NATURE REVIEWS GENETICS
- Genome editing with engineered zinc finger nucleases
- (2010) Fyodor D. Urnov et al. NATURE REVIEWS GENETICS
- Mixed T cell receptor dimers harbor potentially harmful neoreactivity
- (2010) M. M. van Loenen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- (2009) A. Di Stasi et al. BLOOD
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Adoptive cell therapy for the treatment of patients with metastatic melanoma
- (2009) Steven A Rosenberg et al. CURRENT OPINION IN IMMUNOLOGY
- Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors
- (2009) T Maetzig et al. GENE THERAPY
- Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance
- (2009) Noemi Soto-Nieves et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting
- (2009) A. D. Wells JOURNAL OF IMMUNOLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication
- (2009) Xiao-Song Zhong et al. MOLECULAR THERAPY
- Molecular regulation of T-cell anergy
- (2008) Yan Zheng et al. EMBO REPORTS
- Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct
- (2008) J A Curtin et al. GENE THERAPY
- Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2
- (2008) Bianca Heemskerk et al. HUMAN GENE THERAPY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-?? Receptor
- (2008) Aaron E. Foster et al. JOURNAL OF IMMUNOTHERAPY
- Chemical control of protein stability and function in living mice
- (2008) Laura A Banaszynski et al. NATURE MEDICINE
- Distinct sets of TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues
- (2008) L. Derre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation
- (2007) Agnes Shuk Yee Lo et al. MOLECULAR IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started